The University of Chicago Header Logo

Connection

Nancy Jean Cox to Azathioprine

This is a "connection" page, showing publications Nancy Jean Cox has written about Azathioprine.
Connection Strength

0.897
  1. PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine. Clin Transl Sci. 2025 Jun; 18(6):e70220.
    View in: PubMed
    Score: 0.220
  2. Race, Genotype, and Azathioprine Discontinuation : A Cohort Study. Ann Intern Med. 2022 08; 175(8):1092-1099.
    View in: PubMed
    Score: 0.179
  3. Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity. Clin Transl Sci. 2022 04; 15(4):859-865.
    View in: PubMed
    Score: 0.175
  4. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. Clin Pharmacol Ther. 2022 01; 111(1):263-271.
    View in: PubMed
    Score: 0.171
  5. Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practice. Pharmacogenomics J. 2020 10; 20(5):736-745.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.